The past year was a difficult one for the nation and the healthcare industry in particular. As it turns out, value-based care could've played an even greater role in improving population health and...
FDA’s full approval of the Pfizer-BioNTech vaccine will have implications for mandates alongside the financial motivation coming from more payers regarding cost-sharing for COVID-19 treatments...
HIMSS is rounding out its last few days of the Global Health Conference with vendor announcements of new technologies that specialize in patient data collection, diagnostic testing, and patient...
A heatwave has set in in the Northeast, and many of us are hot and bothered.
North Carolina Residents File Antitrust Suit Against HCA Healthcare
A group of North Carolina residents has filed a...
Companies and vendors announced new partnerships and offerings that aim to benefit both patients and providers on the third day of the HIMSS Global Health Conference.
FHIR API Offers Free Testing for...
On day two of HIMSS21, vendors revealed solutions for combatting long waits for appointment check-ins, cybersecurity breaches, and germs. Aetna also introduced a new way to receive primary care...
The annual HIMSS Global Health Conference and Exhibition kicked off this week in Las Vegas. A number of technology vendors introduced new products and ideas that ultimately seek to speed up...
Reading the news, it is becoming increasingly difficult to shake feelings of déjà-vu...
AHA Challenges UnitedHealth’s Acquisition of Change Healthcare
In a letter to the...
Let me tell you: A week away from work feels great. Now it's time to turn our attention back to healthcare.
Medicare’s Inpatient Payments Will Increase 2.5% in 2022
CMS has finalized an...
Hospitals were never thrilled with the Hospital Price Transparency rule, and a recent independent review shows they have done little to comply with the regulation aimed at helping consumers choose...
In the modern-day take on A Tale of Two Cities, the threat of COVID-19 has become a matter of where you live, putting clearly in harm's way those without the power to be vaccinated or avoid the...
Happy Tuesday! Folks on either coast of the United States are facing either record high temperatures or levels of rainfall. As is the case most times, meteorologists are the only ones satisfied.
FDA...
While the pandemic shone a bright light on mental health, many Americans faced struggles accessing counseling services due to cost and other barriers. As Delta variant becomes the dominant strain of...
Welcome back to work after a long (and for many in the Northeast rainy) weekend. Direct-to-consumer marketing appears to be paying off for pharma companies as far as Medicare drug spending is...
Remote patient monitoring (RPM) took off during the coronavirus pandemic, but the industry will have to take decisive steps in order to build on that momentum, according to Eric Wicklund, senior editor...
United States officials have paused the distribution of Eli Lilly’s COVID-19 antibody therapy after it proves ineffective against variants. New research shows the ground ambulance rides are...
In perhaps a wake-up call to pharmaceutical companies, pharmacy benefit managers, and payers, data from GoodRx shows that its platform has generated $30 billion in savings for consumers to date. In...
Real-world data shows that Gilead’s remdesivir reduces the risk of mortality for COVID-19 patients. Precision medicine is set for advancement at Weill Cornell Medicine with the launch of a...
Telehealth growth could continue to improve access to care after the coronavirus pandemic, but policymakers and the healthcare industry will have to address certain barriers to telehealth to make that...
Good news: A Phase 3 study of Regeneron’s COVID-19 antibody cocktail shows that the therapy is effective in reducing the risk of death for patients suffering from the virus. The bad news:...
